Table 3. Significantly different proposed monosaccharide compositions (p < 0.05) when tumor tissue samples from CRC patients were compared.
| Composition | Group | Neutral or acidic | Fold change | FDR-adjusted p-value |
|---|---|---|---|---|
| H3N5 | Right-sided CRC vs. left-sided CRC, stage II samples only | Neutral | 4,66 | 0,01 |
| H5N4F3P1 | Right-sided CRC, stage II vs. III | Acidic | 5,43 | 0,009 |
| H4N5F3P1 | Stage II vs III CRC, all samples | Acidic | 5,27 | 0,043 |
| H4N5F3P1 | Right-sided CRC, stage II vs. III | Acidic | 9,04 | 0,022 |
| H6N5F4P1 | Right-sided CRC, stage II vs. III | Acidic | 6,16 | 0,009 |
| S1H6N6F2 | Stage II vs III CRC, all samples | Acidic | 4,31 | 0,044 |
| S1H6N7F3 | Stage II vs III CRC, all samples | Acidic | 15,18 | 0,038 |
| H9N8P1 | Right-sided CRC, stage II vs. III | Acidic | 6,02 | 0,019 |
| S1H7N7F4 | Stage II vs III CRC, all samples | Acidic | N/A | 0,038 |
Additional details can be found in S1 and S3 Tables. The subgroup within which the levels of a specific monosaccharide composition are higher are highlighted in bold. The fold change for the composition S1H7N7F4 is not available, as the relative abundance was 0.25 in stage II samples, while S1H7N7F4 was not detected at all in any of the stage III samples (with a relative abundance of 0.00).